Nuveen S&P 500 Dynamic Overwrite Fund is a US-based company operating in industry. The company is headquartered in Chicago, Illinois. The company went IPO on 2005-11-23. Nuveen S&P 500 Dynamic Overwrite Fund (the Fund) is a diversified, closed-end management investment company. The Fund’s investment objective is to seek an attractive total return with less volatility than the S&P 500 Index. Under normal circumstances, the Fund invests at least 80% of its assets in a diversified equity portfolio made up of securities consisting of the S&P 500 Index that seeks to substantially replicate price movements of the S&P 500 Index and is designed to support the Fund’s option strategy. The company also invests in other investment companies, including exchange-traded funds (ETFs), that provide similar exposure to individual common stocks consistent with the Fund’s investment objective. The company invests in various sectors, including aerospace and defense, beverages, biotechnology, capital markets, chemicals, communications equipment, diversified telecommunication services, entertainment, consumer finance, and others. The Fund's investment adviser is Nuveen Fund Advisors, LLC.
根據最新的財務報表(Form-10K),Hinge Health Inc 的總資產為 $0,淨損失為 $0
SPXX 的關鍵財務比率是什麼?
Hinge Health Inc 的流動比率為 0,淨利潤率為 0,每股銷售為 $0。
Nuveen S&P 500 Dynamic Overwrite Fund 的收入按細分市場或地理位置如何劃分?
Hinge Health Inc 最大收入來源為 Artificial Intelligence-Powered Motion Tracking Technology and Proprietary Electrical Nerve Stimulation Wearable Device,在最近的收益報告中收入為 587,860,000。就地區而言,United States 是 Hinge Health Inc 的主要市場,收入為 587,860,000。